A carregar...
Clinical development of phosphatidylinositol 3-kinase inhibitors for non-Hodgkin lymphoma
Phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling pathway is extensively explored in cancers. It functions as an important regulator of cell growth, survival and metabolism. Activation of this pathway also predicts poor prognosis in numerous human malignancies....
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4177547/ https://ncbi.nlm.nih.gov/pubmed/24252186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-7771-1-30 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|